Simbec-Orion Group Ltd
Simbec Research has over 35 years' experience in clinical drug development, specialising in healthy and patient volunteer studies. Simbec's Phase I-IIa services include: first into man phase I studies, single and multi-dose tolerability; proof of concept phase IIa studies; drug-drug interaction studies; bioavailability/bioequivalence studies; mass balance/ADME/microdosing; genotyping/phenotyping; bioanalytical services (including assay development); central laboratory services; and QTc studies. Support services include: regulatory, protocol and report writing, medical writing, project management, and data management and statistics pharmacokinetics. Niche services include: ophthalmic research, gamma scintigraphy, dermatology and respiratory.